The results of screening for prostate cancer in men aged up to 55 years
D. T Tarend , O. G Sukonko , S. A Krasny , Svyataslau A. Semenov , A. V Karman
Russian Journal of Oncology ›› 2016, Vol. 21 ›› Issue (1-2) : 47 -50.
The results of screening for prostate cancer in men aged up to 55 years
In an analysis of 5414 men aged 45-55 years with a PSA level > 4 ng/ml, who underwent 6 point biopsy under ultrasound control, during the first round of screening 21 prostate cancer (PCa) cases were diagnosed, that accounted 0,4% of all examined men. To improve the diagnostic for PCa in the second round of screening it was proposed to decline PSA to 2,5 ng/ml as a threshold, and in case of its excess to perform 12points biopsy. Due to this modification the detection of PCa was increased by 1,85 times. Perhaps, introducing of this method will help to make early detection for PCa more effectively.
prostate cancer / screening / PSA / early detection
| [1] |
Океанов А.Е., Моисеев П.И., Левин Л.Ф. Статистика онкологических заболеваний в Республике Беларусь (2004-2013). Минск: РНПЦ ОМР им. Н.Н. Александрова; 2014. |
| [2] |
Океанов А.Е., Моисеев П.И., Красный С.А., Поляков С.Л., Евмененко А.А. Рак предстательной железы в Республике Беларусь. Онкологический журнал. 2012; 1: 15-24. |
| [3] |
Суконко О.Г., Красный С.А., Океанов А.Е., Моисеев П.И., Поляков С.Л. Рак предстательной железы в Республике Беларусь: вчера, сегодня, завтра. Здравоохранение. 2013; 11: 34-42. |
| [4] |
Heidenreich A., Abrahamsson P., Artibani W., Catto J., Montorsi F., Van Poppel H. et al. Early detection of prostate cancer: european association of urology recommendation. Eur. Urol. 2013; 64 (3): 347-54. |
| [5] |
Antenor J.A., Han M., Roehl K.A., Nadler R.B., Catalona W.J. Relationship between initial prostate specific antigen level and subsequent prostate cancer detection in a longitudinal screening study. J. Urol. 2004; 172: 90-3. |
| [6] |
Takechi H., Ito K., Yamamoto T., Ohi M., Kubota H. Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less. Prostate. 2003; 57: 8-13. |
| [7] |
Roobol M.J., Roobol D.W., Schröder F.H. Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/ml or less in a population-based screening setting? (ERSPC, section Rotterdam). Urology. 2005; 65: 343-6. |
Eco-Vector
/
| 〈 |
|
〉 |